Advanced glycation end products and vascular inflammation: implications for accelerated atherosclerosis in diabetes.
about
Receptor for advanced glycation end products and its involvement in inflammatory diseasesIntensive Diabetes Treatment and Cardiovascular Disease in Patients with Type 1 DiabetesDo advanced glycation end-products play a role in malaria susceptibility?Does accumulation of advanced glycation end products contribute to the aging phenotype?CD36: implications in cardiovascular diseaseTargeting Reactive Carbonyl Species with Natural Sequestering AgentsDiabetic Cardiovascular Disease Induced by Oxidative StressThe role of triterpenes in the management of diabetes mellitus and its complicationsType 2 diabetes and cognitive impairment: linking mechanismsOxidative stress, insulin resistance, dyslipidemia and type 2 diabetes mellitusOxidative stress and diabetes: what can we learn about insulin resistance from antioxidant mutant mouse models?Alzheimer's disease and type 2 diabetes: multiple mechanisms contribute to interactionsModified Lipids and Lipoproteins in Chronic Kidney Disease: A New Class of Uremic ToxinsAGEs, autofluorescence and renal functionCommercial processed soy-based food product contains glycated and glycoxidated lunasin proteoformsAdvanced glycation end products stimulate gene expression of fibroblast growth factor 23.Differences between healthy adults and patients with type 2 diabetes mellitus in reactivity of toe microcirculation by ultrasound combined with a warm bath testThe hydrolyzable gallotannin, penta-O-galloyl-β-D-glucopyranoside, inhibits the formation of advanced glycation endproducts by protecting protein structure.Glycated hemoglobin and its spinoffs: Cardiovascular disease markers or risk factors?Flow-dependent cellular mechanotransduction in atherosclerosis.Functional decorations: post-translational modifications and heart disease delineated by targeted proteomics.Vessel shrinkage as a sign of atherosclerosis progression in type 2 diabetes: a serial intravascular ultrasound analysisD-ribosylation induces cognitive impairment through RAGE-dependent astrocytic inflammation.Tranilast Blocks the Interaction between the Protein S100A11 and Receptor for Advanced Glycation End Products (RAGE) V Domain and Inhibits Cell ProliferationMolten globule of hemoglobin proceeds into aggregates and advanced glycated end products.Controlled tetra-Fc sialylation of IVIg results in a drug candidate with consistent enhanced anti-inflammatory activity.Relationship of an advanced glycation end product, plasma carboxymethyl-lysine, with slow walking speed in older adults: the InCHIANTI study.Advanced glycation end products influence oral cancer cell survival via Bcl-xl and Nrf-2 regulation in vitroSerum carboxymethyl-lysine, a dominant advanced glycation end product, is associated with chronic kidney disease: the Baltimore longitudinal study of aging.Effects of a new advanced glycation inhibitor, LR-90, on mitigating arterial stiffening and improving arterial elasticity and compliance in a diabetic rat model: aortic impedance analysis.Dietary intake of advanced glycation end products did not affect endothelial function and inflammation in healthy adults in a randomized controlled trial.Anti-inflammatory Actions of Adjunctive Tetracyclines and Other Agents in Periodontitis and Associated Comorbidities.The nuclear factor-kappaB-interleukin-6 signalling pathway mediating vascular inflammation.Anti-receptor for advanced glycation end products therapies as novel treatment for abdominal aortic aneurysmRegulation of high-density lipoprotein on hematopoietic stem/progenitor cells in atherosclerosis requires scavenger receptor type BI expression.Molecular mechanisms of vascular dysfunction and cardiovascular biomarkers in type 2 diabetes.Analysis of in vitro oxidized human LDL phospholipids by solid-phase extraction and micellar electrokinetic capillary chromatography.Advanced glycation/glycoxidation endproduct carboxymethyl-lysine and incidence of coronary heart disease and stroke in older adultsInfluence of +1245 A/G MT1A polymorphism on advanced glycation end-products (AGEs) in elderly: effect of zinc supplementationGlyco-oxidation and cardiovascular complications in type 2 diabetes: a clinical update
P2860
Q21285070-12C9F336-8C8C-402A-8712-F2C5B1779EB9Q22250887-D67CFB4F-1AFE-4444-87B4-CD9C6A292B22Q24471760-F874A91A-A968-4CD1-8E7E-28BAE8C6594CQ24632710-113B9CDB-3736-4E3C-86CB-C0DFB33C2A72Q24678338-C795EF0F-3D35-41CC-ACF6-93440363AD50Q26765482-6FE1FC46-CD3A-4F97-A788-4C3C8478D610Q26778017-424D2FED-2DF2-45EC-B3B4-F3302EACCD83Q26799404-53258774-7108-4AC2-9155-0C9CAD00024CQ26822993-68FA6B42-8236-4465-9B22-CF00132BDC96Q26829529-ADD9FD83-1666-40D6-B7C4-A95F5CEF4AE4Q26853196-EDD910B6-E8D2-4684-93BD-99F68BA14509Q26864965-FBE00FC3-0304-4D00-AF8E-F8FED888CC42Q28074264-EF8FAC5F-288A-4E2C-9B9F-D288DED331BAQ28301793-B06462F8-0C65-4292-A7E4-3C2E8454B4E0Q28834062-53C2A052-8B1A-4680-94F9-07476A4A5BFFQ30313507-94281101-323A-43C6-88F9-759C3A2256CFQ30354434-3B32C55C-B5E4-4334-842E-96C929A02998Q30372854-94702B3E-807F-4643-9FAA-718A2620A942Q30378579-1A3DEA74-2FE2-4496-B653-26E500843B21Q30409536-0F0A6F31-18DC-4A0B-8518-CC85D8621737Q30427683-FC394273-A93F-495C-9789-39CAD86F8B47Q30484282-62002646-1C95-4C6C-BA8A-1EFB15461AD8Q30575300-1D2CADD8-A670-4049-BA0A-C621E74D6182Q31102154-EE3A096E-F282-4D47-AAC0-89EEE9FA990FQ31132290-0B79B0DA-7750-4DB2-B045-E8C444CF1BAEQ33420853-EBE21E02-5439-42D4-AA8B-A1AC83EBF7E4Q33603990-A0E7ACBE-93ED-4700-8498-3C7FA45B86C0Q33686550-10AFBDB3-355A-4DE7-9A2E-E6688D957270Q33691339-AC607DA9-21B0-4773-B0C2-88F48BB11C35Q33746869-BD720677-DE18-418B-8643-530817F1CAD8Q33752140-2A25D974-5000-4548-9A54-1C510C473D3BQ33815397-7BAAC6C3-710E-46A8-A624-1C2995278556Q34030580-102AE023-D4AC-4137-94B7-627D9A9CFF83Q34067128-51D4833A-D33E-4D80-90C7-99A427AA6398Q34076242-1495F51B-8C30-4B0B-AAB0-52443DF1ADCFQ34099937-96458166-A928-4C3F-86D1-2B1B2D3ACD9DQ34185357-7410EF78-F6D5-47DA-ACD8-00F944D830E3Q34217710-33CB2065-B09B-4AB3-924D-90EA615711E6Q34232756-D9A5BF46-6F1A-44D3-B62C-DB9595E0C073Q34286094-E96C5DF1-D556-4E94-A16F-409AA0ED0C98
P2860
Advanced glycation end products and vascular inflammation: implications for accelerated atherosclerosis in diabetes.
description
2004 nî lūn-bûn
@nan
2004年の論文
@ja
2004年論文
@yue
2004年論文
@zh-hant
2004年論文
@zh-hk
2004年論文
@zh-mo
2004年論文
@zh-tw
2004年论文
@wuu
2004年论文
@zh
2004年论文
@zh-cn
name
Advanced glycation end product ...... d atherosclerosis in diabetes.
@ast
Advanced glycation end product ...... d atherosclerosis in diabetes.
@en
type
label
Advanced glycation end product ...... d atherosclerosis in diabetes.
@ast
Advanced glycation end product ...... d atherosclerosis in diabetes.
@en
prefLabel
Advanced glycation end product ...... d atherosclerosis in diabetes.
@ast
Advanced glycation end product ...... d atherosclerosis in diabetes.
@en
P1476
Advanced glycation end product ...... ed atherosclerosis in diabetes
@en
P2093
Ann Marie Schmidt
Raffaele De Caterina
P304
P356
10.1016/J.CARDIORES.2004.05.001
P577
2004-09-01T00:00:00Z